# FDA 483 - Patrick Odia, MD - February 16, 2024

Source: https://www.keypedia.com/records/483/patrick-odia-md/7438a6f8-f162-404c-b3f5-4d50fa6446f7

> FDA 483 for Patrick Odia, MD on February 16, 2024. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Patrick Odia, MD
- Inspection Date: 2024-02-16
- Product Type: other
- Office Name: Division of Human and Animal Food Operations - West III
- Summary: An FDA inspection of Patrick Odia, MD in Houston, TX, a clinical investigator site, revealed a significant issue regarding the conduct of an investigation. The primary finding was that the investigator failed to adequately supervise the study, specifically concerning the assessment of subject eligibility by a sub-investigator. This indicates a lack of adherence to the signed statement of investigator and the investigational plan.

## Related Officers

- [Habacuc V. Barrera](https://www.keypedia.com/people/habacuc-v-barrera/d4149e5b-7424-4ab8-b7f1-23988c83d9cf)

Company: https://www.keypedia.com/companies/patrick-odia-md/5177a202-235c-46f8-8ea5-cd016462a5ab

Office: https://www.keypedia.com/offices/division-of-human-and-animal-food-operations-west-iii/2cda09a5-06c4-433f-9df0-0d7903a6efab